Use Frequencies: Cancer: Colon:
0.02, 0.03, 0.04, 5.03, 119.34, 350, 434.33, 691.27, 759.83, 927.1
Carcinoma of the sigmoid colon is a form of colorectal cancer that develops in the sigmoid colon, the S-shaped segment of the large intestine near the rectum. Common symptoms include blood in the stool, abdominal discomfort, changes in bowel habits, and unintended weight loss.
Alternative Treatment Program (Methylene Blue, Ivermectin, Mebendazole)
(1) In addition to Rife Digital frequency therapies, some alternative approaches have been explored: Methylene blue has been studied for it’s potential role in disrupting cancer cell metabolism through electron cycling and NF-kB pathway inhibition. Suggested dosing ranges from 0.5–2 mg/kg, administered intravenously or orally.
(2) Ivermectin, traditionally an antiparasitic, has shown interest in cancer research due to its ability to inhibit PAK1, a protein involved in tumor growth, and its anti-angiogenic properties. Experimental dosing for cancer applications has been considered at 0.2–0.4 mg/kg orally.
(3) Mebendazole, an anti-helminthic drug, has demonstrated potential in disrupting microtubule function in cancer cells, similar to certain chemotherapy agents. Some off-label protocols suggest 100–200 mg daily.
